Is BMY or MCK cheaper?

On trailing earnings, BMY is cheaper: BMY trades at a 15.17 P/E and MCK at 19.51.

Which has grown faster, BMY or MCK?

Over the past five years, MCK grew revenue faster — BMY at a 2.52% CAGR versus MCK at 11.11%.

Does BMY or MCK pay a bigger dividend?

BMY yields 4.63% and MCK yields 0.44% based on trailing dividends and the latest price.

Is BMY or MCK more profitable?

BMY runs the higher net margin — BMY at 15.01% versus MCK at 1.18%.

Which has been the better investment, BMY or MCK?

Over the past 10-year, MCK delivered the higher annualized total return — BMY at 0.79% versus MCK at 16.38%. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs McKesson Corporation (MCK)

BMY leads on 9 of 16 compared metrics.

A side-by-side comparison of Bristol-Myers Squibb Company and McKesson Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BMY

Bristol-Myers Squibb Company

Total return — BMY vs MCK

growth of $100 · last 30y

BMY +153.2%MCK +2978.9%MCK compounded faster

Log scale — wide-divergence pair

BMY MCK

BMY vs MCK: by the numbers

•BMY is the larger company ($110.27B vs $87.88B market cap).
•BMY trades at the lower earnings multiple (15.17 vs 19.51 P/E).
•BMY converts more revenue to profit (15.01% vs 1.18% net margin).
•MCK grew revenue faster over the past five years (11.11% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.63% vs 0.44%).

Which is better, BMY or MCK?

Metric tally: BMY 9 · MCK 7

It depends on what you're optimizing for:

ValueBMY(lower P/E)

GrowthMCK(faster 5Y revenue CAGR)

IncomeBMY(higher dividend yield)

QualityMCK(higher ROIC)

Metrics side by side

Valuation

Metric	BMY	MCK
P/E ratio	15.17●	19.51
Forward P/E	8.80●	14.90
P/S ratio	2.28	0.23●
P/B ratio	5.50	—
PEG ratio	1.62	0.46●
EV / EBITDA	10.57●	13.79
FCF yield	10.79%●	6.44%

Profitability

Metric	BMY	MCK
Gross margin	68.75%●	3.61%
Operating margin	25.67%●	1.58%
Net margin	15.01%●	1.18%
ROE	36.25%●	-219.24%
ROIC	13.90%	31.48%●

Dividends

Metric	BMY	MCK
Dividend yield	4.63%●	0.44%
Payout ratio	72.25%	8.51%

Growth (annualized)

Metric	BMY	MCK
Revenue CAGR (5Y)	2.52%	11.11%●
EPS CAGR (5Y)	9.38%	40.71%●
FCF CAGR (5Y)	-2.50%	8.76%●
Total return CAGR (5Y)	-0.13%	33.07%●

Frequently asked

Which is better, BMY or MCK?: It depends on your goal. value: BMY (lower P/E); growth: MCK (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: MCK (higher ROIC). Across all compared metrics, BMY leads 9 to 7.
Is BMY or MCK cheaper?: On trailing earnings, BMY is cheaper: BMY trades at a 15.17 P/E and MCK at 19.51.
Which has grown faster, BMY or MCK?: Over the past five years, MCK grew revenue faster — BMY at a 2.52% CAGR versus MCK at 11.11%.
Does BMY or MCK pay a bigger dividend?: BMY yields 4.63% and MCK yields 0.44% based on trailing dividends and the latest price.
Is BMY or MCK more profitable?: BMY runs the higher net margin — BMY at 15.01% versus MCK at 1.18%.
Which has been the better investment, BMY or MCK?: Over the past 10-year, MCK delivered the higher annualized total return — BMY at 0.79% versus MCK at 16.38%. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full MCK analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio McKesson P/E ratio Bristol-Myers Squibb dividend yield McKesson dividend yield Bristol-Myers Squibb ROE McKesson ROE Bristol-Myers Squibb operating margin McKesson operating margin Bristol-Myers Squibb revenue growth McKesson revenue growth Bristol-Myers Squibb free cash flow McKesson free cash flow

Bristol-Myers Squibb & McKesson appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 20, 2026.